Wednesday, February 10, 2010, 8:33am EST - Canadian Markets open in 57 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Conceptus, Inc. (CPTS)

 On Feb 9: 21.17 USD   0.00 (0.00%)  
MORE ON CPTS
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Conceptus, Inc. (NGM:CPTS) Delayed quote dataEdit
Last Trade: 21.17 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 21.17
Open: N/A
Bid: 20.45 x 500
Ask: 21.15 x 100
1y Target Est: 22.20
Day's Range: N/A - N/A
52wk Range: 10.26 - 21.29
Volume: 0
Avg Vol (3m): 242,278
Market Cap: 650.49M
P/E (ttm): 72.01
EPS (ttm): 0.29
Div & Yield: N/A (N/A%)
Conceptus, Inc. (CPTS)
1d  5d  3m  6m  1y  2y  5y  max 
 Add CPTS to Portfolio   Download Data

HEADLINES
• Award Winning Equity Analyst Sees 2010 Increase In Mergers And Acquisitions In Life Science Tools And Diagnostics Sector
Wall Street Transcript (Wed, Feb 3)
• Conceptus® to Introduce 2010 Guidance and Hold Fourth Quarter Financial Results Conference Call February 23, 2010
Business Wire (Fri, Jan 29)
• Health-Care Stocks Watch Mass. Senate Race Today
at Barrons.com (Tue, Jan 19)
• Olympian Picabo Street Announces She Just Had the Essure® Permanent Birth Control Procedure
Business Wire (Tue, Jan 12)
• Conceptus® To Present at the 28th Annual JP Morgan Healthcare Conference
Business Wire (Thu, Dec 17)
• Conceptus® to Present at the OneMedPlace Finance Forum
Business Wire (Wed, Dec 16)
• This Big Winner Has Hit Its Prime
at Motley Fool (Fri, Nov 27)
• Conceptus® to Present at the Piper Jaffray 21st Annual Healthcare Conference
Business Wire (Tue, Nov 17)
• CONCEPTUS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
• Conceptus Earnings Call scheduled for 4:30 pm ET today
CCBN (Wed, Oct 21)
• CONCEPTUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements a
EDGAR Online (Wed, Oct 21)
More Headlines for CPTS...
ANALYST
EPS Est (next year) (Dec-09) : 0.25
EPS Est (in 2 years) (Dec-10) : 0.55
Avg Rec (current)*: 2.4
PEG Ratio: 2.82
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications in the United States. The company offers Essure, a permanent birth control system for women.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices